Refractory Or Resistant Cd19 Acute Lymphoblastic Leukemia clinical trials

Explore recruiting refractory or resistant cd19 acute lymphoblastic leukemia clinical trials.

Recruiting refractory or resistant cd19 acute lymphoblastic leukemia studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Refractory Or Resistant Cd19 Acute Lymphoblastic Leukemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Single-center phase I/IIa study of infusion of autologous peripheral blood T cells expanded and genetically modified by Sleeping Beauty family transposons to express a chimeric antigen receptor with anti-CD19 specificity conjugated with the 4-1BB costimulatory region and CD3z and huEGFRt signal transmission (TranspoCART19) in patients with CD19+ acute lymphoblastic leukemia resistant or refractory to treatment

Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Refractory Or Resistant Cd19 Acute Lymphoblastic Leukemia trials by city

Refractory Or Resistant Cd19 Acute Lymphoblastic Leukemia in Toronto Refractory Or Resistant Cd19 Acute Lymphoblastic Leukemia in Vancouver Refractory Or Resistant Cd19 Acute Lymphoblastic Leukemia in Montreal Refractory Or Resistant Cd19 Acute Lymphoblastic Leukemia in Calgary Refractory Or Resistant Cd19 Acute Lymphoblastic Leukemia in Edmonton Refractory Or Resistant Cd19 Acute Lymphoblastic Leukemia in Ottawa Refractory Or Resistant Cd19 Acute Lymphoblastic Leukemia in Winnipeg Refractory Or Resistant Cd19 Acute Lymphoblastic Leukemia in Quebec City Refractory Or Resistant Cd19 Acute Lymphoblastic Leukemia in Hamilton Refractory Or Resistant Cd19 Acute Lymphoblastic Leukemia in Kitchener Refractory Or Resistant Cd19 Acute Lymphoblastic Leukemia in London Refractory Or Resistant Cd19 Acute Lymphoblastic Leukemia in Halifax Refractory Or Resistant Cd19 Acute Lymphoblastic Leukemia in New York Refractory Or Resistant Cd19 Acute Lymphoblastic Leukemia in Los Angeles Refractory Or Resistant Cd19 Acute Lymphoblastic Leukemia in Chicago Refractory Or Resistant Cd19 Acute Lymphoblastic Leukemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease